The National Centre for Research and Development (NCBR) and Polpharma S.A. have signed a funding agreement for an innovative project aimed at implementing a new generation of RNA‑based medicines. The project will receive over PLN 30 million in funding from the European Funds for a Modern Economy programme, under the critical technologies support instrument – STEP.
Read more